ライフサイエンスコーパス: bowel movement

1 elated condition, and 1 due to high baseline bowel movements).

2 tinal effects (nausea, vomiting, and altered bowel movements).

3 ecreased stool consistency and time to first bowel movement.

4 was efficacy regarding change in spontaneous bowel movements.

5 f days per week with one or more spontaneous bowel movements.

6 ndardized questionnaires and daily number of bowel movements.

7 f patients with constipation have infrequent bowel movements.

8 S]) with incontinence, urgency, and frequent bowel movements.

9 eported on average 5 daytime and 1 nighttime bowel movements.

10 recovery across multiple parameters: earlier bowel movement (1.21 +/- 0.34 vs. 2.20 +/- 0.57 days, p

11 Patients had four bowel movements/24 hours and good fecal control, which c

12 She reported frequent soft bowel movements (5-6 times per day), as well as flatulen

13 nts (90% v 69%; P = .004), and bleeding with bowel movements (57% v 35%; P = .01).

14 2%), rare/no urgency (68%) with median daily bowel movements 7 (range 2-20).

15 in the octreotide group, including nocturnal bowel movements (70% v 45%; P = .004), clustering of bow

16 vements (70% v 45%; P = .004), clustering of bowel movements (90% v 69%; P = .004), and bleeding with

17 istory of bloody diarrhea consisting of 8-12 bowel movements a day, weight loss of 10 kg and peripher

18 orter time to the first postdose spontaneous bowel movement and a higher mean number of days per week

19 Secondary endpoints included time to first bowel movement and length of postoperative hospital stay

20 stool frequency, stool consistency, ease of bowel movement and quality of life.

21 estion, a correlation between the pattern of bowel movement and the type of excreted gas, a prevalenc

22 Her bleeding is associated with bowel movements and a sense of incomplete evacuation.

23 l habits, including frequency of spontaneous bowel movements and complete spontaneous bowel movements

24 rain interaction characterized by infrequent bowel movements and hard stools, which substantially aff

25 in 141 cloaca patients: 82 have spontaneous bowel movements and satisfactory control, 38 use enemas

26 al starch fibers on beneficial gut bacteria, bowel movements and stool consistency were evaluated aft

27 Frequency of bowel movements and symptoms of frequency, nocturnal bow

28 rollment, time to first postdose spontaneous bowel movement, and mean number of days per week with on

29 t urine leak, necrotic pancreatitis, delayed bowel movement, and severe shoulder pain secondary to di

30 urgent bowel movements, lack of control over bowel movements, and difficulty fully emptying the bowel

31 suggesting that high-fiber diet and frequent bowel movements are associated with a greater and not lo

32 A high-fiber diet and increased frequency of bowel movements are associated with greater, rather than

33 a tryptophan hydroxylase inhibitor, reduces bowel movement (BM) frequency in patients with carcinoid

34 nal pain (80.4%) while passage of blood with bowel movements (BM) (86.6%) and loose/watery BMs (86.5%

35 data to 10 years show that median number of bowel movements (bms) was 6 bm/24 hours at all time inte

36 treatment as usual on defecation frequency [bowel movements (BMs)/wk] or treatment success rates in

37 CI: 2.26, 6.84) (P(trend) < 0.0001) across 4 bowel movement categories.

38 Daily number of bowel movements changed from a median of 7 (interquartil

39 Subjects with lower bowel movement clarity scores were more likely to have i

40 Bowel movements, clustering, and FISI scores were simila

41 Number of daily bowel movements, consistency of the stools, and abdomina

42 ed to assess whether the clarity of the last bowel movement could predict inadequate bowel preparatio

43 vements and symptoms of frequency, nocturnal bowel movements, cramping, and bleeding returned close t

44 point was three or more complete spontaneous bowel movements (CSBMs) per week and an increase of one

45 o achieve three or more complete spontaneous bowel movements (CSBMs) per week, the stimulant diphenyl

46 d point was clinical cure (firm stools or <3 bowel movements daily) at day 14 and no disease recurren

47 Patients with more than 3 bowel movements/day and indication of colonoscopy were e

48 hours (P=0.03), the median time to the first bowel movement decreased from 111 to 70 hours (P=0.01),

49 Daily number of bowel movements decreased from a median of 5 (interquart

50 factors associated with achieving voluntary bowel movements defined as continence.

51 ominal pain in conjunction with bloating and bowel movement disorder.

52 age (<75 vs >/=75 years), number of unformed bowel movements during previous 24 hours (<10 vs >/=10),

53 h men with daily bowel movements, men with a bowel movement every 3 days or less had a multivariate-a

54 s, the relative risks associated with having bowel movements every third day or less, compared with t

55 n increase from baseline of >/=1 spontaneous bowel movements for >/=9 of 12 weeks and for >/=3 of the

56 c output, specifically time and frequency of bowel movements, for all participants by daily post-slee

57 However, little is known about whether bowel movement frequency affects risk of cardiovascular

58 rapy is associated with a slight increase in bowel movement frequency and decrease in several patient

59 and 200 mg also had greater improvements in bowel movement frequency and urgency, global symptoms, q

60 d indicate that simple questions directed at bowel movement frequency are unlikely to enhance our abi

61 The authors prospectively examined bowel movement frequency at baseline in relation to futu

62 Our results suggest increased bowel movement frequency is a potential risk factor for

63 In the Nurses' Health Study, bowel movement frequency was self-reported in 1982 by 86

64 es (frequency of problematic abdominal pain, bowel movement frequency, facial oedema severity, and pe

65 ospectively examined the association between bowel movement frequency, laxative use, and the risk of

66 d to softened stool and a modest increase in bowel movement frequency, resulting from increased stool

67 owed colonic transit with consequent reduced bowel-movement frequency, and difficulty with the act of

68 Abnormal bowel movements have been related to various cardiovascu

69 k factors, as compared with women with daily bowel movement, having bowel movements more than once da

70 ea-predominant IBS (IBS-D) or IBS with mixed bowel movements (IBS-M).

71 Patients with new-onset diarrhea (>=3 bowel movements in any 24 hour period in the 48 hours be

72 Patients with new-onset diarrhea (>=3 bowel movements in any 24-hour period in the 48 hours be

73 relative to manometric results, frequency of bowel movements, incontinence scores, or overall patient

74 by a combination of symptoms such as urgent bowel movements, lack of control over bowel movements, a

75 ot support an association between infrequent bowel movement, laxative use, and risk of colorectal can

76 JP patients had fewer bowel movements, less clustering, used fewer pads and ha

77 Clarity of last bowel movement may be useful indicator in predicting poo

78 In conclusion, infrequent bowel movements may antedate the onset of cardinal motor

79 In the HPFS, compared with men with daily bowel movements, men with a bowel movement every 3 days

80 with women with daily bowel movement, having bowel movements more than once daily was significantly a

81 rease in the number of spontaneous, complete bowel movements of one or more per week, on average, as

82 acterized by chronic abdominal pain, altered bowel movements, often accompanied by somatic and psychi

83 third day or less, compared with those with bowel movements once daily, were 0.94 (95% confidence in

84 ical conditions, nor does it appear to delay bowel movement or hospital discharge.

85 surgery and then twice daily until the first bowel movement or until discharge from the hospital.

86 evelopment of symptomatic CDC (defined as >3 bowel movements per 24 hours and a positive cytotoxin as

87 The average number of bowel movements per 24 hours at 6 months was 4.8.

88 Subjects on the GCD had more bowel movements per day (P = .04); the GCD had a greater

89 At 1 year, the mean number of bowel movements per day had increased from 1.75 to 2.09

90 The number of bowel movements per day increased up to week 4 and then

91 y (P = .04); the GCD had a greater effect on bowel movements per day of HLA-DQ2/8-positive than HLA-D

92 ever, some had severe diarrhea with 10 to 40 bowel movements per day or had persistent/chronic diarrh

93 the 12-week response rate (>/=3 spontaneous bowel movements per week and an increase from baseline o

94 are both effective, increasing the number of bowel movements per week by 1.8 (95 % Crl 1.0, 2.8) and

95 wel movements per week, individuals with >15 bowel movements per week had a 70% greater risk for dive

96 nts with three or more spontaneous, complete bowel movements per week was 30.9% of those receiving 2

97 constipation (< or =2 spontaneous, complete bowel movements per week) received placebo or 2 or 4 mg

98 s having three or more spontaneous, complete bowel movements per week, averaged over 12 weeks.

99 Compared to individuals with <7 bowel movements per week, individuals with >15 bowel mov

100 The primary outcome was the mean number of bowel movements per week.

101 ant increase in the percentage of successful bowel movements (PRE: median 43% [0-100] vs ON: 89% [11-

102 believe that a high-fiber diet and frequent bowel movements prevent the development of diverticulosi

103 ous bowel movements and complete spontaneous bowel movements (primary end point), severity of straini

104 e identify alcohol consumption frequency and bowel movement quality as unexpectedly strong sources of

105 A responder had at least three spontaneous bowel movements (SBMs) per week with an increase from ba

106 Symptom assessments included spontaneous bowel movements (SBMs), complete SBMs, stool consistency

107 cantly higher (p = 0.023) and rates of loose bowel movements tended to be lower (p = 0.053) in the tr

108 roup had 1 more symptom-day of more frequent bowel movements than did controls (3.7 symptom-days comp

109 ffected metabolic outputs, measured by later bowel movements than WT participants.

110 vention of recurrence, durable response, and bowel movement urgency.

111 se, endoscopic remission, and improvement in bowel-movement urgency.

112 Subjects recorded the clarity of their last bowel movement using a 5-point scale prior to colonoscop

113 Voluntary bowel movement (VBM) was achieved in 82% of subjects.

114 The mean number of bowel movements was fewer than 3 per day.

115 g skills who had a mean of >/= 3 spontaneous bowel movements/week and </= 1 episode of fecal incontin

116 espectively, had a mean of </= 1 spontaneous bowel movements/week.

117 s, mean times to passage of flatus and first bowel movement were 3.6 +/- 0.2 days and 4.4 +/- 0.2 day

118 Baseline bowel movements were 2.3/day, with 35% of the patients h

119 f days per week with one or more spontaneous bowel movements were observed with 25 mg of naloxegol ve

120 sistency, ease of passage, and time to first bowel movement with a strong dose response for stool con

121 The patient complained about irregular bowel movements with intermittent diarrhea for two month

122 srectal catheter reported severe limitation (bowel movement), with no reports of any serious effect o

123 with a significantly increased frequency of bowel movements, with subjects reporting these as health

124 clean on enemas or continent with voluntary bowel movements without the need for enemas.

125 -2.5 h) and increased stool frequency by 1.3 bowel movements/wk (95% CI: 0.7, 1.9 bowel movements/wk)

126 MD: 1.5 bowel movements/wk; 95% CI: 0.7, 2.3 bowel movements/wk) but not for Lactobacillus casei Shir

127 by 1.3 bowel movements/wk (95% CI: 0.7, 1.9 bowel movements/wk), and this was significant for Bifido

128 : -0.2 bowel movements/wk; 95% CI: -0.8, 0.9 bowel movements/wk).

129 t for Lactobacillus casei Shirota (WMD: -0.2 bowel movements/wk; 95% CI: -0.8, 0.9 bowel movements/wk

130 ificant for Bifidobacterium lactis (WMD: 1.5 bowel movements/wk; 95% CI: 0.7, 2.3 bowel movements/wk)